http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2012129675-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-522 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4402 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4402 |
| filingDate | 2010-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2012129675-A |
| titleOfInvention | THERAPEUTIC COMBINATIONS OF THEOBROMIN AND ANTIHISTAMINE |
| abstract | 1. The drug (medication), including theobromine and antihistamine as a combined drug for simultaneous, sequential or separate use in therapy. 2. The agent of claim 1, wherein the therapy is a cough treatment. The agent according to claim 1, wherein the antihistamine is selected from diphenhydramine, loratadine, desloratadine, alimemazine, dimenhydrinate, doxylamine, meclizine, quetiapine, fexofenadine, pheniramine, cetirizine, promethazine, clemastine, chlorpheniramine, dexinazinazinofermene azinorisinofenamerin hydrochlorofin astemizole, fexofenadine, loratadine, cetirizine, levocetirizine, brompheniramine, dextrobrompheniramine, promethazine, misolastine and triprolidine. 4. The agent of claim 3, wherein the antihistamine is chlorpheniramine. 5. The agent according to any one of claims 1 to 4, wherein the dose of antihistamine for administration is from 0.1 to 30 mg / kg / day. A pharmaceutical composition comprising theobromine and an antihistamine. 7. A composition according to claim 6 wherein the antihistamine is selected from diphenhydramine, loratadine, desloratadine, alimemazine, dimenhydrinate, doxylamine, meclizine, Quetiapine, Fexofenadine, pheniramine, cetirizine, promethazine, clemastine, chlorpheniramine, dexchlorpheniramine, levocetirizine, hydroxyzine, alimemazine, acrivastine, cyproheptadine, astemizole, fexofenadine, loratadine, cetirizine, levocetirizine, brompheniramine, dextrobrompheniramine, promethazine, misolastine and triprolidine. 8. The composition of claim 7, wherein the antihistamine is chlorpheniramine. A composition according to any one of claims 6 to 8, wherein the dose of antihistamine for administration is from 0.1 to 30 mg / kg / day. The use of pharmaceutical com |
| priorityDate | 2009-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 60.